Literature DB >> 411134

Genetically determined immune hyperreactivity in human liver disease.

A L Eddleston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 411134      PMCID： PMC1543300     

Source DB:  PubMed          Journal:  Proc R Soc Med        ISSN： 0035-9157


× No keyword cloud information.
  18 in total

1.  Letter: HL-A and idiopathic Addison's disease.

Authors:  P Platz; L Ryder; L S Nielsen; A Svejgaard; M Thomsen; J Nerup; M Christy
Journal:  Lancet       Date:  1974-08-03       Impact factor: 79.321

2.  High prevalence of seroimmunologic abnormalities in relatives of patients with active chronic hepatitis or primary biliary cirrhosis.

Authors:  R M Galbraith; M Smith; R M Mackenzie; D E Tee; D Doniach; R Williams
Journal:  N Engl J Med       Date:  1974-01-10       Impact factor: 91.245

Review 3.  Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity.

Authors:  A C Allison; A M Denman; R D Barnes
Journal:  Lancet       Date:  1971-07-17       Impact factor: 79.321

4.  Increased incidence of HL-A 1 and 8 in patients showing IgG or complement coating on their red cells.

Authors:  J A Da Costa; A G White; A C Parker; G B Grigor
Journal:  J Clin Pathol       Date:  1974-05       Impact factor: 3.411

5.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

6.  Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

Authors:  A M Cochrane; A Moussouros; A D Thomsom; A L Eddleston; R Wiiliams
Journal:  Lancet       Date:  1976-02-28       Impact factor: 79.321

7.  Letter: HL-A 1,8 phenotype and HBs antigenaemia in haemodialysis patients.

Authors:  J F Bach; J Zingraff; B Descamps; C Naret; P Jungers
Journal:  Lancet       Date:  1975-10-11       Impact factor: 79.321

8.  Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting.

Authors:  R M Galbraith; A L Eddleston; R Williams; A D Webster; J Pattison; D Doniach; L A Kennedy; J R Batchelor
Journal:  Lancet       Date:  1976-05-01       Impact factor: 79.321

9.  HL-A system and diabetes mellitus.

Authors:  A G Cudworth; J C Woodrow
Journal:  Diabetes       Date:  1975-04       Impact factor: 9.461

10.  HLA and pancreatic islet cell antibodies in diabetes.

Authors:  P J Morris; W J Irvine; R S Gray; L J Duncan; H Vaughan; F J McCallum; C J Campbell; J W Farquhar
Journal:  Lancet       Date:  1976-09-25       Impact factor: 79.321
View more
  2 in total

1.  Increased sensitivity to concanavalin A and a suppressor cell defect in chronic active hepatitis.

Authors:  C de Galocsy; P J Jenkins; G Mieli-Vergani; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

2.  A new cryopathic syndrome.

Authors:  M Caudron; C Bieva; E Laurent; F De Meuter; W W Feremans; P Lebas; C L Malmendier
Journal:  J Clin Pathol       Date:  1980-09       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.